NeuroSense Therapeutics Ltd. — SC 13G Filings
5 SC 13G filings on record
This page lists all SC 13G filings submitted to the SEC by NeuroSense Therapeutics Ltd. (NRSNW), sorted by most recent first. Each row links to the full filing on EdgarLookup. NeuroSense Therapeutics Ltd. has filed 5 SC 13G documents with the SEC since 2021. To view all SEC filings by NeuroSense Therapeutics Ltd., see the full filings list.
All
20-F
3
424B3
424B4
424B5
6-K
6-K/A
8-A12B
AW
CERT
CORRESP
D
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-3
FWP
POS AM
POS EX
S-8
SC 13G
SC 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G | SCHEDULE 13G | 0001213900-24-106912 | Dec 9, 2024 | — |
| SC 13G | SCHEDULE 13G | 0001213900-23-020257 | Mar 15, 2023 | — |
| SC 13G | SCHEDULE 13G | 0001213900-21-068039 | Dec 30, 2021 | — |
| SC 13G | SCHEDULE 13G | 0001213900-21-067350 | Dec 23, 2021 | — |
| SC 13G | SCHEDULE 13G | 0001213900-21-066375 | Dec 20, 2021 | — |